Introduction {#sec1}
============

AzaBODIPY (the BF~2~ complex of azadipyrromethene, [Chart [1](#cht1){ref-type="chart"}](#cht1){ref-type="chart"}) shows a strong absorption band at wavelengths above 650 nm, large molar extinction coefficients, and high photostability. This class of dyes has attracted wide-ranging research interest in biomedicine and materials science, for example, as photosensitizers (for photodynamic therapy), sensors, and near-infrared labeling agents.^[@ref1]−[@ref5]^ BODIPY, as the *meso*-carbon analogue of azaBODIPY ([Chart [1](#cht1){ref-type="chart"}](#cht1){ref-type="chart"}), has been extensively studied.^[@ref6],[@ref7]^ There are many well-established methods available for the facile postfunctionalization of BODIPY. By contrast, few research efforts have been devoted to the postfunctionalization of azaBODIPY. Recently, some postfunctionalization methods have developed based on Pd-catalyzed coupling (Suzuki,^[@ref8]^ Stille,^[@ref9]^ and Sonogashira,^[@ref10]^[Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) reactions^[@ref8]−[@ref11]^ on β-halogenated (brominated or iodinated) azaBODIPYs. These postfunctionalization methods although elegant generally require the use of a transition metal catalyst. In addition, the yields are far from optimal (\<50%). In some coupling reactions, a tedious purification process is required due to the partial removal of the BF~2~ unit under those reaction conditions.

![(a) Currently available postfunctionalization methods for azaBODIPY dyes based on haloazaBODIPY platforms. (b) The concept of our postfunctionalization strategy based on the Wittig reaction on the β-formylazaBODIPY platform presented in this work.](ao-2017-00393v_0001){#fig1}

![Core Structures of BODIPY and azaBODIPY](ao-2017-00393v_0008){#cht1}

As part of our continuous research efforts in the preparation of functionalized azaBODIPYs, we have recently reported several strategies (thiophene-fusion,^[@cit12a]^ "push-pull"^[@cit12b]^ and "conformation-restriction"^[@cit12c]^) for the fine tuning of the optical properties of azaBODIPYs. We have previously reported the regioselective β-formylation of BODIPYs and have successfully extended this reaction to the azaBODIPY system.^[@ref13]^ Those resultant β-formylBODIPYs have received wide-ranging research interest in a highly diverse research fields.^[@ref14],[@ref15]^ We rationalized that these resultant β-formylazaBODIPYs may be applied for the Wittig reaction^[@cit14d],[@ref16]^ to achieve the facile postfunctionalization of the azaBODIPY chromophore ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). With our recent progress in the regioselective β-bromination of β-formylazaBODIPYs, we anticipated that the resultant β-bromo-β′-formylazaBODIPY may be used as a privileged platform in the facile postfunctionalization of the azaBODIPY system. Herein, we report the facile preparation of a series of β-vinyl ketone/ester functionalized azaBODIPYs via a straightforward Wittig reaction on β-formylazaBODIPYs, as well as the X-ray structures, the photophysical properties, and the electrochemical properties of these resultant dyes.

Results and Discussion {#sec2}
======================

Syntheses {#sec2.1}
---------

β-FormylazaBODIPYs **2a**--**c** were prepared in good (75--86%) yields from readily available azaBODIPYs **1a**--**c** using our previously established formylation procedure ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"})^[@cit13a]^ and were characterized by NMR and HRMS analysis. Their further regioselective bromination smoothly proceeded with liquid bromine^[@ref17]^ and generated the corresponding β-bromo-β′-formylazaBODIPYs **3a**--**c** in excellent (91--95%) isolated yields.

![Synthesis of β-FormylazaBODIPYs **2a**--**c** and β-Bromo-β′-formylazaBODIPYs **3a**--**c**](ao-2017-00393v_0005){#sch1}

These resultant β-formylazaBODIPYs **2a**--**c** and **3a**--**c** smoothly reacted with various readily available phosphonium ylides **5a**--**c**^[@cit14d],[@ref16]^ under Wittig reaction conditions (80 °C in toluene), from which the desired β-vinyl ketone/ester functionalized azaBODIPYs **4a**--**h** were isolated as the major products in 43--83% yields ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). These resultant azaBODIPYs **4a**--**h** were characterized via NMR and HRMS analysis. The structures of azaBODIPYs **4a** and **4b** and their key synthetic precursors **2a** and **2b** were further confirmed by X-ray analysis ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). This Wittig reaction uses readily available starting materials (β-formylazaBODIPYs and phosphonium ylide reagents) and mild reaction conditions and shows good compatibility with various functionalities. It was found that the electron-donating substituents in azaBODIPYs **1** increase the reactivity of this formylation and the subsequent Wittig reaction and the yields of these two reactions. The ester moiety may be further hydrolyzed to generate a carboxylic acid group, which provides the desired water solubility and a valuable site for conjugation with the biomolecule and solid surface.

![Top and front views of the X-ray structures of (a) **2a**, (b) **2b**, (c) **4a**, and (d) **4b**. C, light gray; H, gray; N, blue; B, dark yellow; F, bright green; O, red.](ao-2017-00393v_0002){#fig2}

![Synthesis of β-Vinyl Ketone/Ester Functionalized azaBODIPYs **4a**--**h** and the Further Functionalization of **4d** via Suzuki Coupling Reaction](ao-2017-00393v_0007){#sch2}

The remaining bromo substituent in azaBODIPYs **4d**, **4e**, and **4f** provides the desired heavy-atom effect to facilitate their applications as photosensitizers. In addition, this bromo substituent also provides a valuable site for various coupling reactions including the Suzuki coupling reaction demonstrated in this work ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). The Suzuki coupling of azaBODIPY **4d** with 4-(diphenylamino)phenylboronic acid smoothly proceeded to generate azaBODIPY **4k** in 47% isolated yield. The installation of triphenylamine, an important unit in many electronic devices, results in an interesting donor--azaBODIPY--acceptor (D−π--A) structure.

X-ray Structures {#sec2.2}
----------------

Crystals suitable for X-ray analysis of azaBODIPYs **2a**, **2b**, **4a**, and **4b** ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}) were obtained via the slow diffusion of petroleum ether into their dichloromethane solutions under ambient conditions. As expected, these azaBODIPY dyes all show an almost planar structure for the azaBODIPY core (defined by the central six-membered C~2~N~3~B ring and two adjacent five-membered pyrrole rings) and a perpendicular arrangement of the plane defined by F--B--F atoms to that of the azaBODIPY core. The B--N distances for these azaBODIPYs are within 1.55--1.58 Å, which indicates the usual delocalization of the positive charge. These azaBODIPYs show a characteristic core structure similar to most of the previously reported azaBODIPY systems.^[@cit1c],[@cit12c]^ The dihedral angles of the four phenyl rings in the dipyrrin core are in the range of 7.7--81.2° ([Table S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00393/suppl_file/ao7b00393_si_001.pdf)), indicating the intramolecular hydrogen bondings between F and the hydrogen atoms on four phenyl moieties. The dihedral angles defined by the two pyrrole units in azaBODIPYs **2a** and **2b** are 12.4 and 14.8°, respectively, which were reduced to 3.8 and 1.1°, respectively, for azaBODIPYs **4a** and **4b**. This indicates that the presence of the β-vinyl ester moiety reduces the distortion of the planar structure of the azaBODIPY chromophore. The average root-mean-square deviation of the 19 atoms (atoms 1--19 labeled in [Figures S5 and S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00393/suppl_file/ao7b00393_si_001.pdf)) from the mean plane of the azaBODIPY **4a** and **4b** cores are 0.0037 and 0.0019 Å, respectively. This indicates that the β-vinyl ester moiety and the C~8~BN~3~ central core nearly stay at the same planar structure. Thus, the installation of this β-vinyl ester moiety indeed extends the π-conjugation of the chromophore.

Photophysical Properties {#sec2.3}
------------------------

The photophysical properties of these resultant azaBODIPYs **4a**--**k** and their key synthetic precursors **2a**--**c** and **3a**--**c** were investigated in chloroform as summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. Each of these dyes, except for **4k**, shows an intense absorption band in the range of 650--690 nm with a molar extinction coefficient (57 400--82 600 cm^--1^ M^--1^) comparable to that of most azaBODIPYs appearing in the literature.^[@cit1c]^ In comparison with azaBODIPYs **2** and **3**, each of the azaBODIPYs **4** shows an around 3--30 nm redshift of the absorption spectra. AzaBODIPY **4k** shows two absorption bands (a strong absorption band centered at 688 nm and a broad shoulder tailing up to 850 nm). The relatively low molar extinction coefficient (31 600 cm^--1^ M^--1^) observed for azaBODIPY **4k** with respect to azaBODIPYs **4a**--**j** may be partially attributed to the extremely broad absorption bands of this dye ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a).

![Overlaid normalized (a) absorption and (b) emission spectra of **2a** (red), **3a** (blue), **4d** (olive), **4k** (purple) in chloroform. Excited at 630 nm for **2a** and **3a**, 640 nm for **4k**, and 650 nm for **4d**.](ao-2017-00393v_0003){#fig3}

###### Photophysical Properties of azaBODIPYs **4a**--**k**, **2a**--**c**, and **3a**--**c** in Chloroform at Room Temperature

  dyes     λ~abs~^max^ (nm)   λ~em~^max^ (nm)   ε~abs~[a](#t1fn1){ref-type="table-fn"} (cm^--1^ M^--1^)   Φ~F~[b](#t1fn2){ref-type="table-fn"}   Stokes-shift (cm^--1^)
  -------- ------------------ ----------------- --------------------------------------------------------- -------------------------------------- ------------------------
  **4a**   684                717               77 000                                                    0.08                                   673
  **4b**   687                722               69 800                                                    0.11                                   706
  **4c**   661                694               71 700                                                    0.04                                   719
  **4d**   682                718               71 700                                                    0.01                                   757
  **4e**   685                720               59 200                                                    0.05                                   710
  **4f**   657                702               70 900                                                    \<0.001                                976
  **4g**   687                720               75 100                                                    0.08                                   667
  **4h**   687                721               71 900                                                    0.01                                   686
  **4i**   687                714               75 300                                                    0.11                                   550
  **4j**   687                719               75 300                                                    0.01                                   648
  **4k**   688                729               55 300                                                    \<0.01                                 817
  **2a**   677                716               66 000                                                    0.26                                   805
  **2b**   657                703               56 200                                                    0.32                                   996
  **2c**   654                716               57 400                                                    0.18                                   1324
  **3a**   679                720               82 600                                                    0.02                                   839
  **3b**   665                709               64 000                                                    0.07                                   933
  **3c**   649                728               57 500                                                    \<0.01                                 1672

Data corresponding to the strongest absorption maximum.

Fluorescence quantum yields were calculated using **1b** (ϕ = 0.36 in chloroform) as the reference. The standard errors are less than 10% from three independent measurements.

Each of the azaBODIPYs **4** shows a weak fluorescence emission in the range 690--730 nm ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). The relatively lower fluorescence emission for those bromo-containing azaBODIPYs may be attributed to the heavy atom effect of the bromo substituent on these azaBODIPYs, which makes these azaBODIPYs potential photosensitizers for dye-sensitized solar cells.^[@ref18]^ The weak fluorescence of azaBODIPY **4k** may be attributed to the nonradiative decay associated with free rotation of the triphenylamine moiety and the internal charge transfer effect from the triphenylamine moiety to the azaBODIPY core.

The solvatochromic effects of three common organic solvents (toluene, chloroform, and methanol) on the absorption and emission properties of azaBODIPYs **4a**--**k** were investigated ([Figures S11--S27](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00393/suppl_file/ao7b00393_si_001.pdf)) as summarized in [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00393/suppl_file/ao7b00393_si_001.pdf). A slight blueshift of the absorption and emission band and a slight decrease in the fluorescence quantum yield were observed with increasing solvent polarity. For example, a slight blueshift of the absorption (from 685 to 672 nm) and emission band (from 719 to 715 nm) and a slight decrease in the fluorescence quantum yield (from 0.10 to 0.04) were observed for azaBODIPY **4a** by changing the solvent from toluene to methanol. Similar solvatochromic behavior has been reported previously for the solution of azaBODIPY **1b**.^[@cit1c]^

Electrochemical Properties {#sec2.4}
--------------------------

The cyclic voltammetry of **1a**, **2a**, **3a**, **4d**, and **4k** were performed in deoxygenated dichloromethane at room temperature with tetrabutylammonium hexafluorophosphate (TBAPF~6~) as the supporting electrolyte ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). Most of these dyes show two reversible reduction waves and one reversible oxidation wave. AzaBODIPYs **2a** and **4d** have reduction potentials more negative than **1a**. This indicates that the installation of electron-withdrawing substituents (formyl and vinyl ester groups) at the β-position of the chromophore increases the electron-deficiency of the chromophore, and makes azaBODIPYs **2a** and **4d** more susceptible to reduction than **1a**. A similar effect was observed for the installation of bromo substituent (**3a**). AzaBODIPY **4k**, containing a strong electron-donating triphenylamine substituent, shows one irreversible reduction at −1.10 V. The highest occupied molecular orbital and lowest unoccupied molecular orbital energy levels for **4d** and **4k** were estimated based on their onset potential of the first oxidation and reduction waves (−5.59 and −4.08 eV for **4d**, −4.95 and −3.51 eV for **4k**, respectively). The calculated electrochemical energy band gap for **4k** is 1.45 eV, which is in good agreement with its optical band gap.

Conclusions {#sec3}
===========

In conclusion, we have developed a new strategy for the facile postfunctionalization of azaBODIPY based on a classic Wittig reaction on our previously reported β-formylazaBODIPYs and our recently developed β-bromo-β′-formylazaBODIPYs. Our strategy uses readily available starting materials, requires mild reaction conditions, and features good yields and good compatibility with various functionalities. The installation of β-vinyl ketone/ester increases the π-conjugation of the system, whereas it has negligible influence on the planar structure of the chromophore. These resultant β-vinyl ketone/ester functionalized azaBODIPY dyes show intense absorption in the NIR range (660--690 nm). The resultant bromo-containing β-vinyl ketone/ester functionalized azaBODIPYs are potential photosensitizers and can be further applied for coupling reactions to generate various β,β′-difunctionalized D−π--A dyes.

Experimental Section {#sec4}
====================

General {#sec4.1}
-------

Reagents and solvents were used as received from commercial suppliers unless noted otherwise. All reactions were performed in oven-dried or flame-dried glassware unless otherwise stated and were monitored by thin-layer chromatography (TLC) using 0.25 mm silica gel plates with a UV indicator (60F-254). ^1^H and ^13^C NMR were recorded on a 300 or 500 MHz NMR spectrometer at room temperature. Chemical shifts (δ) are given in ppm relative to CDCl~3~ (7.26 ppm for ^1^H and 77 ppm for ^13^C) or to internal TMS. High-resolution mass spectra (HRMS) were obtained using APCI-TOF or MALDI-TOF in positive mode.

Photophysical Measurements {#sec4.2}
--------------------------

UV--visible absorption and fluorescence emission spectra were recorded on commercial spectrophotometers (190--900 nm scan range) at room temperature (10 mm quartz cuvette). Relative fluorescence quantum efficiencies of BODIPY derivatives were obtained by comparing the areas under the corrected emission spectrum of the test sample in various organic solvents with that of Rhodamine B (Φ = 0.36 in chloroform).^[@cit10b]^ Nondegassed, spectroscopic grade solvents and a 10 mm quartz cuvette were used. Dilute solutions (0.01 \< *A* \< 0.05) were used to minimize the reabsorption effects. Quantum yields were determined using [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}([@ref19])where subscripts x and r refer, respectively, to our sample x and reference (standard) fluorophore r with known quantum yield *A*~r~ in a specific solvent; *F* stands for the spectrally corrected, integrated fluorescence spectra; *A*(λ~ex~) denotes the absorbance at the used excitation wavelength λ~ex~; and *n* represents the refractive index of the solvent (in principle at the average emission wavelength).

Cyclic Voltammograms {#sec4.3}
--------------------

Cyclic voltammograms of 1 mM **1a**, **2a**, **3a**, **4d**, and **4k** were measured in dichloromethane solution, containing 0.1 M TBAPF~6~ as the supporting electrolyte, a glassy carbon electrode as a working electrode, Pt wire as a counter electrode, and a saturated calomel electrode as a reference electrode at 50 mV s^--1^ scanning rate at room temperature ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}).

![Cyclic voltammograms of 1 mM **1a** (black), **2a** (red), **3a** (blue), **4d** (purple), and **4k** (green) measured in dichloromethane, containing 0.1 M TBAPF~6~ as the supporting electrolyte at room temperature. A glassy carbon electrode is used as the working electrode and the scan rate is 50 mV s^--1^.](ao-2017-00393v_0004){#fig4}

Crystallography {#sec4.4}
---------------

Crystals of **2a**, **2b**, **4a**, and **4b** suitable for X-ray analysis were obtained via the slow diffusion of petroleum ether into their dichloromethane solutions under ambient conditions. The vial containing this solution was placed, loosely capped, to promote the crystallization. A suitable crystal was chosen and mounted on a glass fiber using grease. Data were collected using a diffractometer equipped with a graphite crystal monochromator situated in the incident beam for data collection at room temperature. Cell parameters were retrieved using SMART^[@ref20]^ software and refined using SAINT^[@ref21]^ on all observed reflections. The determination of unit cell parameters and data collection were performed with Mo Kα radiation (λ) at 0.71073 Å. Data reduction was performed using the SAINT software, which corrects for Lp and decay. The structure was solved by the direct method using the SHELXS-974 program and refined by the least squares method on F^2^, SHELXL-97,^[@ref22]^ incorporated in SHELXTL V5.10.^[@ref23]^ CCDC-1547895 (**2a**), CCDC-1547896 (**2b**), CCDC-1519967 (**4a**), CCDC-1519968 (**4b**) contain the supporting crystallographic data for this article. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via [www.ccdc.cam.ac.uk/data_request/cif](www.ccdc.cam.ac.uk/data_request/cif).

Synthesis {#sec4.5}
---------

AzaBODIPYs **1a**--**c**^[@cit1c],[@cit12b]^ and phosphonium ylides **5a**--**c**^[@ref16]^ were synthesized according to the literature.

### General Procedure for the Preparation of β-FormylazaBODIPYs **2a**--**c** {#sec4.5.1}

To the anhydrous dimethylformamide (3 mL) was slowly added POCl~3~ (3 mL) at 0 °C under argon. It was left stirring for 30 min at 0 °C before addition of azaBODIPYs **1a**--**c** (0.3 mmol) in 1,2-dichloroethane (10 mL). The resulting mixture was stirred at 70 °C for 2 h. The reaction mixture was cooled to room temperature and quenched via the slow addition of 10% aqueous solution of K~2~CO~3~ (200 mL). The reaction mixture was further stirred for 50 min and extracted with dichloromethane (30 mL × 3). The organic layers were combined, washed with water, and dried over anhydrous MgSO~4~. The solvent was removed under vacuum. The crude product was further purified with column chromatography using the mixture of petroleum ether and dichloromethane (v/v = 1/2) as eluent to afford the desired β-formylazaBODIPYs **2a**--**c** as a dark cyan solid in 75--86% isolated yields.

**2a** was obtained in 86% isolated yield (166 mg) from **1a** (185 mg, 0.3 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 9.73 (s, 1H), 8.10 (t, *J* = 9.0 Hz, 4H), 7.88 (d, *J* = 9.0 Hz, 2H), 7.70 (d, *J* = 9.0 Hz, 2H), 7.11 (s, 1H) 7.05--6.97 (m, 6H), 6.93 (d, *J* = 9.0 Hz, 2H), 3.92 (s, 3H), 3.89 (s, 3H), 3.88 (s, 3H), 3.87 (s, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 186.7, 164.7, 163.5, 161.8, 161.0(3), 161.0, 158.2, 148.9, 146.4, 140.6, 133.7, 132.3, 131.3, 124.6, 124.0, 123.9, 122.6, 122.2, 119.2, 114.6, 114.3, 113.5, 113.2, 55.6, 55.5, 55.4, 55.3. HRMS (APCI) Calcd for C~37~H~30~BF~2~N~3~O~5~ \[M + H\]^+^ 646.2319, found 646.2328.

**2b** was obtained in 78% isolated yield (137 mg) from **1b** (167 mg, 0.3 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 9.79 (s, 1H), 8.17 (d, *J* = 9.0 Hz, 2H), 8.06 (d, *J* = 6.0 Hz, 2H), 7.82 (brs, 2H), 7.72 (d, *J* = 9.0 Hz, 2H), 7.47 (brs, 3H), 7.42 (d, *J* = 6.0 Hz, 2H), 7.28--7.23 (m, 2H), 7.04--7.00 (m, 4H), 3.89 (brs, 6H). ^13^C NMR (75 MHz, CDCl~3~) δ: 186.9, 165.6, 164.3, 161.5, 158.3, 149.4, 147.2, 141.9, 133.5, 132.7, 132.3, 131.4, 130.9, 129.9, 129.8, 129.4, 129.1, 128.6, 128.0, 125.6, 122.7, 122.5, 121.9, 115.2, 113.9, 56.0, 55.7. HRMS (APCI) Calcd for C~35~H~26~BF~2~N~3~O~3~ \[M + H\]^+^ 586.2108, found 586.2105.

**2c** was obtained in 75% isolated yield (131 mg) from **1c** (167 mg, 0.3 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 9.70 (s, 1H), 8.10 (d, *J* = 9.0 Hz, 2H), 8.03 (d, *J* = 9.0 Hz, 2H), 7.91 (d, *J* = 9.0 Hz, 2H), 7.71 (d, *J* = 6.0 Hz, 2H), 7.50--7.45 (m, 6H), 7.07 (d, *J* = 3.0 Hz, 2H), 7.03 (brs, 1H), 6.95 (d, *J* = 9.0 Hz, 2H), 3.92 (s, 3H), 3.89 (s, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 186.8, 162.4, 161.8, 160.1, 149.1, 147.5, 142.7, 142.5, 134.3, 132.7, 131.8, 130.9, 130.8, 130.6, 130.4, 130.2, 129.2, 128.4, 125.3, 124.5, 124.1, 119.6, 114.9, 113.8, 55.9, 55.8(6). HRMS (APCI) Calcd for, C~35~H~26~BF~2~N~3~O~3~ \[M + H\]^+^ 586.2108, found 586.2100.

### General Procedure for the Bromination of β-FormylazaBODIPYs **2a**--**c** To Generate **3a**--**c** {#sec4.5.2}

To β-formylazaBODIPYs **2a**--**c** (0.6 mmol) in 50 mL dichloromethane was added liquid bromine (0.7 mmol). The mixture was stirred at room temperature for 5 min and quenched via the addition of an aqueous solution of sodium bicarbonate (30 mL, 1 M). The reaction mixture was washed with brine and extracted with dichloromethane (50 mL × 3). The organic layers were combined, dried over anhydrous Na~2~SO~4~, and the organic solvent was removed under vacuum. The residue was purified by column chromatography on silica using the mixture of petroleum ether and dichloromethane (v/v = 2/1) as eluent to afford the target azaBODIPYs **3a**--**c** as a dark cyan solid in 91--95% isolated yields.

**3a** was obtained in 95% isolated yield (412 mg) from **2a** (387 mg, 0.6 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 9.72 (s, 1H), 7.94 (d, *J* = 9.0 Hz, 2H), 7.87 (d, *J* = 9.0 Hz, 2H), 7.82 (d, *J* = 9.0 Hz, 2H), 7.68 (d, *J* = 9.0 Hz, 2H), 7.01--6.96 (m, 8H), 3.89 (brs, 6H), 3.87 (s, 3H), 3.86 (s, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 186.2, 162.3, 161.7, 161.6, 161.3, 160.9, 146.1, 144.8, 143.7, 143.1, 134.1, 132.7, 132.2, 125.2, 123.2, 123.0, 121.6, 121.4, 113.8, 113.7, 113.6, 113.4, 110.7, 55.5, 55.4, 55.3. HRMS (MALDI) Calcd for C~37~H~29~BBrF~2~N~3~O~5~ \[M + H\]^+^ 724.1424, found 724.1385.

**3b** was obtained in 91% isolated yield (362 mg) from **2b** (351 mg, 0.6 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 9.79 (s, 1H), 7.89--7.84 (m, 4H), 7.78 (d, *J* = 6.0 Hz, 2H), 7.70 (d, *J* = 9.0 Hz, 2H), 7.48--7.43 (m, 6H), 7.00 (t, *J* = 7.5 Hz, 4H), 3.88 (s, 3H), 3.86 (s, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 186.2, 162.5, 161.7, 161.6, 160.7, 146.4, 145.5, 144.3, 143.1, 132.8, 132.3, 132.0, 130.9, 130.1, 128.1, 127.8, 126.0, 121.4, 121.0, 113.8, 113.6, 112.8(4), 112.7(9), 55.4, 55.3. HRMS (APCI) Calcd for C~35~H~25~BBrF~2~N~3~O~3~ \[M + H\]^+^ 664.1213, found 664.1211.

**3c** was obtained in 93% isolated yield (369 mg) from **2c** (351 mg, 0.6 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 9.69 (s, 1H), 7.97 (d, *J* = 9.0 Hz, 2H), 7.91 (d, *J* = 9.0 Hz, 2H), 7.74 (d, *J* = 6.0 Hz, 2H), 7.67 (d, *J* = 9.0 Hz, 2H), 7.50--7.46 (m, 6H), 7.02 (d, *J* = 9.0 Hz, 2H), 6.99 (d, *J* = 9.0 Hz, 2H), 3.91 (brs, 6H). ^13^C NMR (75 MHz, CDCl~3~) δ: 185.9, 162.2, 162.0, 161.7, 161.5, 146.1, 145.4, 143.8, 143.3, 134.2, 132.7, 131.3, 130.6, 130.2, 130.1, 129.3, 129.0, 128.0, 125.3, 123.1, 123.0, 113.8, 113.5, 110.5, 55.5. HRMS (APCI) Calcd for C~35~H~25~BBrF~2~N~3~O~3~ \[M + H\]^+^ 664.1213, found 664.1209.

### General Procedure for the Preparation of azaBODIPYs **4a**--**j** from Wittig Reaction {#sec4.5.3}

To freshly distilled toluene (3 mL) in a dry Schlenk tube was added β-formylazaBODIPYs **2a**--**c** and **3a**--**c** (0.14 mmol) and phosphorus ylides **5a**--**c** (1 mmol). The mixture was degassed via three freeze--pump--thaw cycles at −78 °C before purging with argon again. The mixture was then heated to 80 °C. TLC was used to follow the reaction. Upon completion of the reaction, the mixture was cooled to room temperature and washed with brine. The organic layers were combined, dried over anhydrous Na~2~SO~4~, and the solvent was removed under vacuum. The residue was purified by column chromatography on silica using the mixture of petroleum ether and dichloromethane (v/v = 1/2) as eluent to afford the desired azaBODIPYs **4a**--**j** as a dark cyan solid in 43--79% isolated yields.

Compound **4a** was obtained in 56% isolated yield (202 mg) from **2a** (322 mg, 0.5 mmol) and **5a** (348 mg, 1 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 8.04 (d, *J* = 9.0 Hz, 4H), 7.63--7.57 (m, 5H), 7.03 (t, *J* = 7.5 Hz, 5H), 6.94--6.87 (m, 4H), 5.78 (d, *J* = 15.0 Hz, 1H), 4.13(q, *J* = 7.0 Hz, 2H), 3.91 (s, 3H), 3.88 (s, 3H), 3.84 (brs, 6H), 1.23 (t, *J* = 7.5 Hz, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 167.5, 162.8, 162.3, 161.2, 160.8, 160.3, 155.5, 147.5, 145.0, 142.8, 139.7, 136.3, 132.5, 132.2, 131.8, 131.0, 130.3, 129.2, 124.6, 124.4, 123.4, 123.2, 119.0, 118.2, 114.4, 114.1, 113.8, 60.3, 55.4, 55.3, 14.3. HRMS (APCI) Calcd for C~41~H~36~BF~2~N~3~O~6~ \[M + H\]^+^ 716.2738, found 716.2729.

Compound **4b** was obtained in 43% isolated yield (141 mg) from **2b** (292 mg, 0.5 mmol) and **5a** (348 mg, 1 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 8.08--8.02 (m, 4H), 7.64--7.57 (m, 5H), 7.50 (d, *J* = 9.0 Hz, 3H), 7.37 (brs, 3H), 7.11 (brs, 1H), 7.04 (d, *J* = 9.0 Hz, 2H), 6.94 (d, *J* = 9.0 Hz, 2H), 5.80 (d, *J* = 15.0 Hz, 1H), 4.14 (q, *J* = 7.0 Hz, 2H), 3.89 (s, 3H), 3.83 (s, 3H), 1.23 (t, *J* = 7.5 Hz, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 167.3, 163.0, 162.4, 160.9, 156.0, 147.5, 145.2, 143.1, 140.2, 135.8, 132.4, 131.8, 131.4, 131.0, 129.9, 129.3, 128.8, 128.6, 128.2, 127.9, 124.3, 123.0, 122.8, 120.1, 119.7, 114.5, 113.8, 60.3, 55.4, 55.3, 14.3. HRMS (APCI) Calcd for C~39~H~32~BF~2~N~3~O~4~ \[M + H\]^+^ 656.2527, found 656.2521.

Compound **4c** was obtained in 50% isolated yield (163 mg) from **2c** (292 mg, 0.5 mmol) and **5a** (348 mg, 1 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 8.06 (d, *J* = 9.0 Hz, 2H), 7.97 (d, *J* = 3.0 Hz, 2H), 7.66--7.60 (m, 4H), 7.54--7.44 (m, 7H), 7.06 (d, *J* = 6.0 Hz, 2H), 6.96--6.90 (m, 3H), 5.68 (d, *J* = 15 Hz, 1H), 4.11 (q, *J* = 6.0 Hz, 2H), 3.92 (s, 3H), 3.87 (s, 3H), 1.21 (brs, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 167.2, 162.7, 161.4, 160.6, 157.0, 145.6, 135.6, 133.9, 132.5, 131.5, 131.1, 130.8, 130.0, 129.8, 129.7, 128.6, 128.3, 127.9, 124.5, 124.3, 124.0, 119.7, 118.1, 114.3, 113.9, 113.3, 60.3, 55.4, 14.2. HRMS (APCI) Calcd for C~39~H~32~BF~2~N~3~O~4~ \[M + H\]^+^ 656.2527, found 656.2532.

Compound **4d** was obtained in 63% isolated yield (249 mg) from **3a** (361 mg, 0.5 mmol) and **5a** (348 mg, 1 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 7.87--7.85 (m, 2H), 7.78 (d, *J* = 9.0 Hz, 2H), 7.59 (d, *J* = 6.0 Hz, 5H), 7.44--7.42 (m, 6H), 6.99 (d, *J* = 6.0 Hz, 4H), 5.75 (d, *J* = 18 Hz, 1H), 4.12 (q, *J* = 6.0 Hz, 2H), 3.88 (brs, 6H), 3.85 (brs, 6H), 1.22 (t, *J* = 6.0 Hz, 3H). δ: 167.0, 161.7, 161.4, 160.9, 160.8, 159.8, 157.9, 144.6, 143.0, 142.1, 135.5, 132.5, 132.4, 131.6, 125.0, 123.9, 123.4, 122.4, 121.9, 120.7, 114.6, 113.9, 113.6(0), 113.5(5), 113.1, 109.1, 60.4, 55.4, 55.3, 29.7, 14.3. HRMS (APCI) Calcd for C~41~H~35~BBrF~2~N~3~O~6~ \[M + H\]^+^ 794.1843, found 794.1838.

Compound **4e** was obtained in 52% isolated yield (191 mg) from **3b** (331 mg, 0.5 mmol) and **5a** (348 mg, 1 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 7.88--7.79 (m, 5H), 7.61 (d, *J* = 8.3 Hz, 4H), 7.54 (s, 1H), 7.47--7.45 (m, 5H), 7.02 (d, *J* = 8.5 Hz, 4H), 5.74 (d, *J* = 16.3 Hz, 1H), 4.15 (q, *J* = 7.0 Hz, 2H), 3.92 (s, 3H), 3.89 (s, 3H), 1.24 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 166.8, 161.8, 161.5, 160.1, 158.1, 135.0, 132.5, 132.0, 131.9, 131.7, 131.1, 130.8(0), 130.7(6), 130.6, 129.5, 129.3, 128.2, 127.9, 127.7, 126.0, 122.2, 121.6, 121.3, 114.4, 114.0, 113.6, 60.4, 55.6, 55.3, 14.2. HRMS (APCI) Calcd for C~39~H~31~BBrF~2~N~3~O~4~ \[M + H\]^+^ 734.1632, found 734.1627.

Compound **4f** was obtained in 57% isolated yield (209 mg) from **3c** (331 mg, 0.5 mmol) and **5a** (348 mg, 1 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 7.93 (d, *J* = 9.0 Hz, 2H), 7.71--7.69 (m, 2H), 7.63 (d, *J* = 9.0 Hz, 2H), 7.56--7.51 (m, 3H), 7.47 (brs, 6H), 7.00 (d, *J* = 9.0 Hz, 4H), 5.63 (d, *J* = 15.0 Hz, 1H), 4.11 (q, *J* = 7.0 Hz, 2H), 3.89 (brs, 6H), 1.20 (t, *J* = 7.5 Hz, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 166.8, 160.9, 160.4, 158.4, 144.6, 143.6, 142.4, 136.9, 135.0, 132.6, 132.4, 130.6, 130.4, 130.2, 129.5, 128.3, 127.9, 125.0, 123.6, 123.3, 120.8, 114.0, 113.6, 108.9, 60.4, 55.4, 14.2. HRMS (APCI) Calcd for C~39~H~31~BBrF~2~N~3~O~4~ \[M + H\]^+^ 734.1632, found 734.1618.

Compound **4g** was obtained in 68% isolated yield (264 mg) from **2a** (322 mg, 0.5 mmol) and **5b** (410 mg, 1 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 8.08 (d, *J* = 3.0 Hz, 2H), 8.05 (d, *J* = 3.0 Hz, 2H), 7.77--7.61 (m, 7H), 7.08 (d, *J* = 3.0 Hz, 2H), 7.05 (d, *J* = 3.0 Hz, 2H), 7.02 (brs, 1H), 6.97--6.83 (m, 7H), 3.92 (s, 3H), 3.90 (s, 3H), 3.87 (s, 3H), 3.85 (s, 3H), 3.84 (s, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 188.0, 163.2, 162.8, 162.3, 161.3, 160.8, 160.3, 155.7, 147.4, 145.2, 142.8, 140.0, 135.2, 132.6, 132.2, 131.8, 131.2, 131.0, 130.5, 124.8, 124.5, 123.7, 123.2, 122.9, 118.1, 114.4, 114.2, 113.9, 113.8, 113.6, 55.4, 55.3. HRMS (APCI) Calcd for C~46~H~38~BF~2~N~3~O~6~ \[M + H\]^+^ 778.2894, found 778.2888.

Compound **4h** was obtained in 83% isolated yield (355 mg) from **3a** (361 mg, 0.5 mmol) and **5b** (410 mg, 1 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 7.92 (d, *J* = 9.0 Hz, 2H), 7.77 (d, *J* = 9.0 Hz, 2H), 7.73--7.59 (m, 7H), 7.03--6.98 (m, 8H), 6.87--6.82 (m, 3H), 3.89 (brs, 6H), 3.87 (s, 3H), 3.86 (s, 3H), 3.84 (s, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 187.8, 163.3, 161.6, 161.3, 160.8, 159.9, 157.9, 144.6, 143.1, 142.2, 134.3, 132.6, 132.4, 131.7, 130.9, 130.5, 129.2, 127.1, 126.0, 124.3, 124.0, 123.4, 122.9, 121.9, 114.0, 113.6(4), 113.5(9), 113.5, 109.0, 55.4. HRMS (APCI) Calcd for C~46~H~37~BBrF~2~N~3~O~6~ \[M + H\]^+^ 856.2000, found 856.1999.

Compound **4i** was obtained in 66% isolated yield (226 mg) from **2a** (322 mg, 0.5 mmol) and **5c** (318 mg, 1 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 8.07 (d, *J* = 9.0 Hz, 4H), 7. 60 (t, *J* = 9.0 Hz, 4H), 7.43 (d, *J* = 15.0 Hz, 1H), 7.06--6.90 (m, 9H), 6.10 (d, *J* = 15.0 Hz, 1H), 3.92 (s, 3H), 3.89 (s, 3H), 3.87 (s, 3H), 3.86 (s, 3H), 2.13 (s, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 198.3, 162.9, 162.7, 161.4, 160.8, 160.3, 155.5, 147.6, 145.3, 142.8, 139.8, 135.3, 132.4, 132.3, 132.2, 131.7, 131.0, 128.0, 124.6, 124.4, 123.4, 123.2, 123.1, 118.3, 114.4, 114.2, 113.8, 55.5, 55.4, 55.2, 27.4. HRMS (APCI) Calcd for C~40~H~34~BF~2~N~3~O~5~ \[M + H\]^+^ 686.2632, found 686.2628.

Compound **4j** was obtained in 79% isolated yield (301 mg) from **3a** (361 mg, 0.5 mmol) and **5c** (318 mg, 1 mmol). ^1^H NMR (300 MHz, CDCl~3~) δ: 7.94 (d, *J* = 9.0 Hz, 2H), 7.80 (d, *J* = 9.0 Hz, 2H), 7.60 (t, *J* = 9.0 Hz, 4H), 7.43 (d, *J* = 18 Hz, 1H), 7.01 (d, *J* = 9.0 Hz, 8H), 6.09 (d, *J* = 18 Hz, 1H), 3.92 (brs, 6H), 3.89 (brs, 6H), 2.16 (s, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ: 198.1, 161.7, 161.4, 160.9, 160.8, 159.5, 158.3, 144.7, 144.5, 143.0, 142.4, 134.4, 132.4(8), 132.4(5), 131.6, 129.2, 124.8, 123.8, 123.4, 122.4, 121.8, 113.9(4), 113.9(2), 113.6(2), 113.5(7), 109.3, 55.4, 55.3, 27.7. HRMS (APCI) Calcd for C~40~H~33~BBrF~2~N~3~O~5~ \[M + H\]^+^ 764.1737, found 764.1730.

Compound **4k**: To a dry Schlenk tube containing **4d** (79 mg, 0.1 mmol), Pd(PPh~3~)~4~ (24 mg, 0.02 mmol), and triphenylamine monoboronic acid (202 mg, 0.7 mmol), were added freshly distilled toluene (2 mL) and the aqueous solution of Na~2~CO~3~ (1 M, 2 mL). The mixture was then degassed via three freeze--pump--thaw cycles at −78 °C before purging with argon again. The mixture was stirred at 80 °C. TLC was used to follow the reaction. Upon completion of the reaction, the reaction mixture was cooled to room temperature, and the mixture was washed with brine (30 mL × 3). The organic layers were combined, dried over anhydrous Na~2~SO~4~, and the solvent was removed under vacuum. The residue was purified by column chromatography on silica using the mixture of petroleum ether and dichloromethane (v/v = 1/2) to afford the desired **4k** as a dark cyan solid in 47% (45 mg) isolated yields. ^1^H NMR (500 MHz, CDCl~3~) δ: 7.62 (d, *J* = 5.0 Hz, 2H), 7.59 (d, *J* = 15.0 Hz, 1H), 7.56 (d, *J* = 10.0 Hz, 2H), 7.50 (d, *J* = 5.0 Hz, 2H), 7.45 (d, *J* = 5.0 Hz, 2H), 7.25--7.23 (m, 4H), 7.07 (d, *J* = 5.0 Hz, 4H), 6.99 (t, *J* = 10.0, 6H), 6.89 (d, *J* = 5.0 Hz, 2H), 6.79 (d, *J* = 10 Hz, 6H), 5.76 (d, *J* = 20.0 Hz, 1H), 4.13 (q, *J* = 8.3 Hz, 2H), 3.89 (s, 3H), 3.86 (s, 3H), 3.83 (s, 3H), 3.81 (s, 3H), 1.22 (t, *J* = 7.5 Hz, 3H). ^13^C NMR (125 MHz, CDCl~3~) δ: 167.3, 162.0, 161.4, 160.9, 160.4, 160.2, 156.9, 147.4, 147.1, 146.7, 143.7, 141.4, 141.0, 136.1, 133.6, 132.5(4), 132.4(7), 131.7, 131.4, 129.3, 126.5, 124.6, 124.4, 124.1, 123.2, 123.0, 122.8, 122.6, 119.5, 113.9, 113.8, 113.4, 113.3, 60.2, 55.4, 55.3, 55.2, 14.3. HRMS (APCI) Calcd for C~59~H~49~BF~2~N~4~O~6~ \[M + H\]^+^ 959.3786, found 959.3785.
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